Oncolytics Biotech GAAP EPS of -$0.07

2 hours ago 1

Oncolytics Biotech press release (NASDAQ:ONCY): Q2 GAAP EPS of -$0.07.
As of June 30, 2025, the Company reported $14.6 million in cash and cash equivalents, projecting a cash runway through key milestones and into the first quarter of 2026.

Recommended For You